Gestational diabetes & diabetes in pregnancy
Optimizing Diabetes Management During Type 1 Diabetes Pregnancy with Automated Insulin Delivery Therapy: Clinical Impact and Economic Consequences in Spain
Authors' conclusion
This conservative analysis captures a clinically significant impact and subsequent economic value, despite being based on only a limited number of perinatal complications.
Study context
- Population
- Pregnant women with T1D, Spanish health care system
- Comparison
- CamAPS FX automated insulin delivery (AID) vs standard of care
- Outcome
- Estimated cost savings per treated woman for the Spanish health care system
- Follow-up
- First year of treatment
Methodological detailsmodel-based, Spanish health care perspective, based on AiDAPT study data
- Model-based
- Spanish health care perspective
- Based on AiDAPT study data
Main finding
As reported in the abstract
Estimated cost savings per treated woman with CamAPS FX AID vs standard of care (SoC)
€1,002
Share of cost savings driven by reductions in intensive neonatal care admissions
81%
Further findings
| Outcome | Values |
|---|---|
| HbA1c in AiDAPT (model input) · baseline to post-treatment | AID mean 6.0 (SD 0.5) % |
- HbA1c in AiDAPT (model input) — Baseline HbA1c with AID
- 7.6% (±1.1)
- HbA1c in AiDAPT (model input) — Incremental HbA1c reduction from first to third trimester with AID over SoC (model basis)
- 0.3%
- HbA1c in AiDAPT (model input): post-treatment value; baseline 7.6% (±1.1)
Original publication
Optimizing Diabetes Management During Type 1 Diabetes Pregnancy with Automated Insulin Delivery Therapy: Clinical Impact and Economic Consequences in Spain. Diabetes Technol Ther. Published 17 February 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →